SEC Form 4 · accession 0001209191-16-138169
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Driscoll
Officer — President and CEO · Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 22, 2016 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2016 | P | 1,000 | $11.20 | A | 19,500 | D | |
| Common Stock | Aug 22, 2016 | P | 1,000 | $11.66 | A | 20,500 | D |
Table II — derivative securities
No Table II lines on this filing.